Statistical Considerations for Clinical Trials During COVID-19: Confirmatory Adaptive Platform Trial (CAPT) Design for COVID-19 Treatment (Part II)

Qing Liu; Karl E. Peace

Statistical Considerations for Clinical Trials During COVID-19: Confirmatory Adaptive Platform Trial (CAPT) Design for COVID-19 Treatment (Part II)

Biostatistics, Epidemiology & Environmental Health Sciences

Research output: Contribution to journal › Article › peer-review

Abstract

Part II of the article that describes confirmatory adaptive platform trial (CAPT) design for COVID-19 treatment development. We describe the methodological foundation of adaptive designs. We provide statistical methods for CAPT design, covering topics on sequential randomizations, adaptive group sequential designs, and sample size adjustment.

Original language	American English
Journal	LinkedIn
State	Published - May 10 2020

Disciplines

Biostatistics
Environmental Public Health
Epidemiology
Public Health

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

https://www.linkedin.com/pulse/statistical-considerations-clinical-trials-during-trial-asa-fellow-1e/?trackingId=U2HupePTTtqXy%2BxIu3WO%2Bg%3D%3D

Cite this

@article{6abd2706667c4dad80c4793ca1ec6c9e,

title = "Statistical Considerations for Clinical Trials During COVID-19: Confirmatory Adaptive Platform Trial (CAPT) Design for COVID-19 Treatment (Part II)",

abstract = " Part II of the article that describes confirmatory adaptive platform trial (CAPT) design for COVID-19 treatment development. We describe the methodological foundation of adaptive designs. We provide statistical methods for CAPT design, covering topics on sequential randomizations, adaptive group sequential designs, and sample size adjustment.",

author = "Qing Liu and Peace, \{Karl E.\}",

year = "2020",

month = may,

day = "10",

language = "American English",

journal = "LinkedIn",

}

TY - JOUR

T1 - Statistical Considerations for Clinical Trials During COVID-19: Confirmatory Adaptive Platform Trial (CAPT) Design for COVID-19 Treatment (Part II)

AU - Liu, Qing

AU - Peace, Karl E.

PY - 2020/5/10

Y1 - 2020/5/10

N2 - Part II of the article that describes confirmatory adaptive platform trial (CAPT) design for COVID-19 treatment development. We describe the methodological foundation of adaptive designs. We provide statistical methods for CAPT design, covering topics on sequential randomizations, adaptive group sequential designs, and sample size adjustment.

AB - Part II of the article that describes confirmatory adaptive platform trial (CAPT) design for COVID-19 treatment development. We describe the methodological foundation of adaptive designs. We provide statistical methods for CAPT design, covering topics on sequential randomizations, adaptive group sequential designs, and sample size adjustment.

UR - https://digitalcommons.georgiasouthern.edu/bee-facpubs/164

UR - https://www.linkedin.com/pulse/statistical-considerations-clinical-trials-during-trial-asa-fellow-1e/?trackingId=U2HupePTTtqXy%2BxIu3WO%2Bg%3D%3D

M3 - Article

JO - LinkedIn

JF - LinkedIn

ER -

Statistical Considerations for Clinical Trials During COVID-19: Confirmatory Adaptive Platform Trial (CAPT) Design for COVID-19 Treatment (Part II)

Abstract

Disciplines

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this